SC
Stephen Curtis
OtherActiveManaging Director at MPM Capital
Boston, United StatesFounded 2014
60
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Stephen Curtis.
Investment Thesis & Strategy
Stephen Curtis, as Managing Director at MPM Capital, invests in various stages of biotech, medical devices, and pharmaceutical companies, seeking to support innovative ventures within the life sciences sector.
Portfolio Companies
Selected investments from their portfolio of 60 companies
S
Syndax Pharmaceuticals
Other · , 0
K
Kalidex Pharmaceuticals
Other · , 0
C
Chiasma
Other · , 0
2
23andMe
Other · , 0
S
Selexys Pharmaceuticals Corporation
Other · , 0
I
Iconic Therapeutics
Other · , 0
D
Dyne Therapeutics
Other · , 0
B
Blade Therapeutics
Other · , 0
T
Theraclone Sciences
Other · , 0
V
Vascular Pharmaceuticals
Other · , 0
C
Celladon
Other · , 0
R
Raze Therapeutics
Other · , 0
Frequently Asked Questions
Stephen Curtis focuses on Seed stage investments.